NCT02323191 2020-08-27A Study of Emactuzumab and Atezolizumab Administered in Combination in Participants With Advanced Solid TumorsHoffmann-La RochePhase 1 Completed221 enrolled
NCT02174172 2020-05-12A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid TumorsHoffmann-La RochePhase 1 Completed158 enrolled